Table of Contents
ISRN Endocrinology
Volume 2011 (2011), Article ID 696124, 6 pages
http://dx.doi.org/10.5402/2011/696124
Clinical Study

Aggressive versus Low Dose Inhibition of the Renin-Angiotensin System for the Treatment of Microalbuminuria in Type 2 Diabetic Patients: A Pilot Study

Department of Internal Medicine, Charles R. Drew University, Los Angeles, CA 90059, USA

Received 19 July 2011; Accepted 15 August 2011

Academic Editor: A. Hishinuma

Copyright © 2011 M. B. Davidson et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. F. M. Strippoli, M. C. Craig, F. P. Schena, and J. C. Craig, “Role of blood pressure targets and specific antihypertensive agents used to prevent diabetic nephropathy and delay its progression,” Journal of the American Society of Nephrology, vol. 17, no. 2, pp. S153–S155, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Ravid, H. Savin, I. Jutrin, T. Bental, B. Katz, and M. Lishner, “Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients,” Annals of Internal Medicine, vol. 118, no. 8, pp. 577–581, 1993. View at Google Scholar · View at Scopus
  3. A. A. M. Zandbergen, M. G. A. Baggen, S. W. J. Lamberts, A. H. Bootsma, D. de Zeeuw, and R. J. T. Ouwendijk, “Effect of losartan on microalbuminuria in normotensive patients with type 2 diabetes mellitus: a randomized clinical trial,” Annals of Internal Medicine, vol. 139, no. 2, pp. 90–96, 2003. View at Google Scholar · View at Scopus
  4. H. Miettinen, S. M. Haffner, S. Lehto, T. Ronnemaa, K. Pyorala, and M. Laakso, “Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects,” Stroke, vol. 27, no. 11, pp. 2033–2039, 1996. View at Google Scholar · View at Scopus
  5. G. I. Papaioannou, R. L. Seip, N. J. Grey et al., “Brachial artery reactivity in asymptomatic patients with type 2 diabetes mellitus and microalbuminuria (from the Detection of Ischemia in Asymptomatic Diabetics-Brachial Artery Reactivity study),” American Journal of Cardiology, vol. 94, no. 3, pp. 294–299, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. S. I. Araki, M. Haneda, D. Koya, A. Kashiwagi, T. Uzu, and R. Kikkawa, “Clinical impact of reducing microalbuminuria in patients with type 2 diabetes mellitus,” Diabetes Research and Clinical Practice, vol. 82, no. 1, pp. S54–S58, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. D. H. O'Leary, J. F. Polak, R. A. Kronmal, T. A. Manolio, G. L. Burke, and S. K. Wolfson, “Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults,” The New England Journal of Medicine, vol. 340, no. 1, pp. 14–22, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Viberti, J. Yip-Messent, and A. Morocutti, “Diabetic nephropathy: future avenue,” Diabetes Care, vol. 15, no. 9, pp. 1216–1225, 1992. View at Google Scholar · View at Scopus
  9. M. B. Davidson, Meeting the American Diabetes Association Standards of Care: An Algorithmic Approach to Clinical Care of the Diabetes Patient, American Diabetes Association, Alexandria, Va, USA, 1st edition, 2010.
  10. A. S. Levey, J. Coresh, T. Greene et al., “Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate,” Annals of Internal Medicine, vol. 145, no. 4, pp. 247–254, 2006. View at Google Scholar
  11. H. N. Hodis, W. J. Mack, L. LaBree et al., “The role of carotid arterial intima—media thickness in predicting clinical coronary events,” Annals of Internal Medicine, vol. 128, no. 4, pp. 262–269, 1998. View at Google Scholar · View at Scopus
  12. P. O. Bonetti, G. M. Pumper, S. T. Higano, D. R. Holmes, J. T. Kuvin, and A. Lerman, “Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia,” Journal of the American College of Cardiology, vol. 44, no. 11, pp. 2137–2141, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. J. T. Kuvin, A. R. Patel, K. A. Sliney et al., “Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude,” American Heart Journal, vol. 146, no. 1, pp. 168–174, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Nohria, M. Gerhard-Herman, M. A. Creager, S. Hurley, D. Mitra, and P. Ganz, “Role of nitric oxide in the regulation of digital pulse volume amplitude in humans,” Journal of Applied Physiology, vol. 101, no. 2, pp. 545–548, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. C. E. Mogensen, “Microalbuminuria as a predictor of clinical diabetic nephropathy,” Kidney International, vol. 31, no. 2, pp. 673–689, 1987. View at Google Scholar · View at Scopus
  16. G. L. Bakris, L. Ruilope, F. Locatelli et al., “Treatment of microalbuminuria in hypertensive subjects with elevated cardiovascular risk: results of the IMPROVE trial,” Kidney International, vol. 72, no. 7, pp. 879–885, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. P. O'Hare, R. Bilous, T. Mitchell et al., “Low-dose ramipril reduces microalbuminuria in type 1 diabetic patients without hypertension: results of a randomized controlled trial,” Diabetes Care, vol. 23, no. 12, pp. 1823–1829, 2000. View at Google Scholar